We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Lab-On-Chip Platform to Expedite Cancer Diagnoses

By LabMedica International staff writers
Posted on 30 Jan 2025

Cancer was responsible for nearly 10 million deaths in 2020, accounting for almost one in every six deaths worldwide. More...

Timely cancer diagnosis remains a major challenge, as abnormal cellular growth is often detected too late. Early diagnosis is critical, and recent research has focused on detecting rare circulating tumor cells (CTCs) in peripheral blood as noninvasive markers for diagnosis. However, isolating target cells for examination is inherently difficult. Traditional methods typically require complex sample preparation, substantial equipment, and large sample volumes, and even then, it remains challenging to efficiently separate the cells.

Researchers from K. N. Toosi University of Technology (Tehran, Iran) have now introduced a groundbreaking system that uses standing surface acoustic waves to separate CTCs from red blood cells with remarkable precision and efficiency. The system developed by the team integrates advanced computational modeling, experimental analysis, and artificial intelligence (AI) algorithms to analyze complex acoustofluidic phenomena. By combining machine learning algorithms with data-driven modeling, they were able to fine-tune the system for optimal recovery and cell separation rates. The platform, described in the journal Physics of Fluids, achieves 100% recovery under ideal conditions, while significantly reducing energy consumption through precise control of acoustic pressures and flow rates.

While many methods for enriching particles through microfluidics have been developed, those using acoustofluidics stand out due to their biocompatibility, ability to generate high-force magnitudes at MPa pressure ranges, and production of cell-scale wavelengths. The researchers' novel approach incorporates dualized pressure acoustic fields, which enhance the impact on target cells, and positions them strategically at critical points in the microchannel geometry on a lithium niobate substrate. By applying acoustic pressure within the microchannel, the system generates reliable datasets that reveal cell interaction times and trajectory patterns, helping to predict tumor cell migration.

“We have produced an advanced, lab-on-chip platform that enables real-time, energy-efficient, and highly accurate cell separation,” said researcher Afshin Kouhkord. “The technology promises to improve CTC separation efficiency and open new possibilities for earlier and more effective cancer diagnosis. It also paves the way for microengineering and applied AI in personalized medicine and cancer diagnostics.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.